rss

Author index

June 2002, Volume 57, Issue 6

[Front cover][Table of contents]
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Arai, H

    • Relationship between asthma severity and progression of Alzheimer's disease Thorax 2002;57:6 561 doi:10.1136/thorax.57.6.561

  2. Ayres, J G

    • Effects of daily variation in outdoor particulates and ambient acid species in normal and asthmatic children Thorax 2002;57:6 489-502 doi:10.1136/thorax.57.6.489

B

  1. Bagg, L R

    • Molecular analysis of drug resistant TB Thorax 2002;57:6 562-563 doi:10.1136/thorax.57.6.562

  2. Behr, J

    • Peripheral airway obstruction in primary pulmonary hypertension Thorax 2002;57:6 473-476 doi:10.1136/thorax.57.6.473

  3. Bellingan, G J

    • The pulmonary physician in critical care • 6: The pathogenesis of ALI/ARDS Thorax 2002;57:6 540-546 doi:10.1136/thorax.57.6.540

  4. Bersten, A D

    • Effect of CPAP on intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD Thorax 2002;57:6 533-539 doi:10.1136/thorax.57.6.533

  5. Blyton, D M

    • Sleep disordered breathing and pregnancy Thorax 2002;57:6 555-558 doi:10.1136/thorax.57.6.555

  6. Boni, E

    • Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest Thorax 2002;57:6 528-532 doi:10.1136/thorax.57.6.528

  7. Borst, M M

    • Peripheral airway obstruction in primary pulmonary hypertension Thorax 2002;57:6 473-476 doi:10.1136/thorax.57.6.473

  8. Breuer, C

    • Peripheral airway obstruction in primary pulmonary hypertension Thorax 2002;57:6 473-476 doi:10.1136/thorax.57.6.473

  9. Brown, T J

    • Molecular analysis of drug resistant TB Thorax 2002;57:6 562-563 doi:10.1136/thorax.57.6.562

  10. Buxton, M

    • Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study Thorax 2002;57:6 503-508 doi:10.1136/thorax.57.6.503

C

  1. Catcheside, P G

    • Effect of CPAP on intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD Thorax 2002;57:6 533-539 doi:10.1136/thorax.57.6.533

  2. Chadwick, M V

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  3. Chen, Y

    • Influence of family income on hospital visits for asthma among Canadian school children Thorax 2002;57:6 513-517 doi:10.1136/thorax.57.6.513

  4. Chiroli, P

    • Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest Thorax 2002;57:6 528-532 doi:10.1136/thorax.57.6.528

  5. Choi, B

    • Influence of family income on hospital visits for asthma among Canadian school children Thorax 2002;57:6 513-517 doi:10.1136/thorax.57.6.513

  6. Colehan, J

    • Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study Thorax 2002;57:6 503-508 doi:10.1136/thorax.57.6.503

  7. Corda, L

    • Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest Thorax 2002;57:6 528-532 doi:10.1136/thorax.57.6.528

  8. Corkill, J E

    • Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives Thorax 2002;57:6 559-560 doi:10.1136/thorax.57.6.559

  9. Creutzberg, E C

    • Pathophysiology of COPD
      1. Commentator:
        • M A Dentener,
        • E C Creutzberg,
        • and E F M Wouters
      Thorax 2002;57:6 563-564 doi:10.1136/thorax.57.6.563-a

  10. Crowe, M

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

D

  1. Dales, R E

    • Influence of family income on hospital visits for asthma among Canadian school children Thorax 2002;57:6 513-517 doi:10.1136/thorax.57.6.513

  2. Damiani, G P

    • Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest Thorax 2002;57:6 528-532 doi:10.1136/thorax.57.6.528

  3. Dentener, M A

    • Pathophysiology of COPD
      1. Commentator:
        • M A Dentener,
        • E C Creutzberg,
        • and E F M Wouters
      Thorax 2002;57:6 563-564 doi:10.1136/thorax.57.6.563-a

  4. Dickens, A

    • Molecular analysis of drug resistant TB Thorax 2002;57:6 562-563 doi:10.1136/thorax.57.6.562

  5. Djuretic, T

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  6. Downie, S R

    • Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms Thorax 2002;57:6 518-523 doi:10.1136/thorax.57.6.518

  7. Downs, S H

    • Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms Thorax 2002;57:6 518-523 doi:10.1136/thorax.57.6.518

  8. Drobniewski, F

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

E

  1. Edwards, N

    • Sleep disordered breathing and pregnancy Thorax 2002;57:6 555-558 doi:10.1136/thorax.57.6.555

  2. Elliott, M W

    • Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature Thorax 2002;57:6 547-554 doi:10.1136/thorax.57.6.547

  3. Evans, T W

    • Pulmonary hypertension A National Pulmonary Hypertension Service for England & Wales: an orphan disease is adopted? Thorax 2002;57:6 471-472 doi:10.1136/thorax.57.6.471

  4. Ewert, R

    • Peripheral airway obstruction in primary pulmonary hypertension Thorax 2002;57:6 473-476 doi:10.1136/thorax.57.6.473

F

  1. Flanagan, P

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  2. Franchini, D

    • Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest Thorax 2002;57:6 528-532 doi:10.1136/thorax.57.6.528

  3. French, G L

    • Molecular analysis of drug resistant TB Thorax 2002;57:6 562-563 doi:10.1136/thorax.57.6.562

  4. Furlong, J

    • Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor Thorax 2002;57:6 524-527 doi:10.1136/thorax.57.6.524

G

  1. Gallagher, M J

    • Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives Thorax 2002;57:6 559-560 doi:10.1136/thorax.57.6.559

  2. Gatzoulis, M A

    • Pulmonary hypertension A National Pulmonary Hypertension Service for England & Wales: an orphan disease is adopted? Thorax 2002;57:6 471-472 doi:10.1136/thorax.57.6.471

  3. Gibbs, J S R

    • Pulmonary hypertension A National Pulmonary Hypertension Service for England & Wales: an orphan disease is adopted? Thorax 2002;57:6 471-472 doi:10.1136/thorax.57.6.471

  4. Godbout, C

    • Independent validation of the Sleep Apnoea Quality of Life Index Thorax 2002;57:6 483-488 doi:10.1136/thorax.57.6.483

  5. Graham, B S

    • Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor Thorax 2002;57:6 524-527 doi:10.1136/thorax.57.6.524

  6. Grassi, V

    • Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest Thorax 2002;57:6 528-532 doi:10.1136/thorax.57.6.528

H

  1. Hardy, K

    • Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study Thorax 2002;57:6 503-508 doi:10.1136/thorax.57.6.503

  2. Harrison, R M

    • Effects of daily variation in outdoor particulates and ambient acid species in normal and asthmatic children Thorax 2002;57:6 489-502 doi:10.1136/thorax.57.6.489

  3. Hart, C A

    • Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives Thorax 2002;57:6 559-560 doi:10.1136/thorax.57.6.559

  4. Hartert, T V

    • Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor Thorax 2002;57:6 524-527 doi:10.1136/thorax.57.6.524

  5. Hashimoto, K

    • Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor Thorax 2002;57:6 524-527 doi:10.1136/thorax.57.6.524

  6. Herbert, J

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  7. Hirata, K

    • Decreased peroxynitrite inhibitory activity in induced sputum in patients with bronchial asthma Thorax 2002;57:6 509-512 doi:10.1136/thorax.57.6.509

  8. Hoeper, M M

    • Peripheral airway obstruction in primary pulmonary hypertension Thorax 2002;57:6 473-476 doi:10.1136/thorax.57.6.473

  9. Hulkkonen, J

    • IL-1 haplotypes and lung function decline
      1. Commentator:
        • L Joos,
        • P D Paré,
        • and A Sandford
      Thorax 2002;57:6 561-562 doi:10.1136/thorax.57.6.561-a

  10. Hurme, M

    • IL-1 haplotypes and lung function decline
      1. Commentator:
        • L Joos,
        • P D Paré,
        • and A Sandford
      Thorax 2002;57:6 561-562 doi:10.1136/thorax.57.6.561-a

  11. Hussain, S

    • Effects of daily variation in outdoor particulates and ambient acid species in normal and asthmatic children Thorax 2002;57:6 489-502 doi:10.1136/thorax.57.6.489

I

  1. Ichinose, M

    • Relationship between asthma severity and progression of Alzheimer's disease Thorax 2002;57:6 561 doi:10.1136/thorax.57.6.561

J

  1. Jarzecka, K

    • Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor Thorax 2002;57:6 524-527 doi:10.1136/thorax.57.6.524

  2. Jones, N

    • Effects of daily variation in outdoor particulates and ambient acid species in normal and asthmatic children Thorax 2002;57:6 489-502 doi:10.1136/thorax.57.6.489

  3. Joos, L

    • IL-1 haplotypes and lung function decline
      1. Commentator:
        • L Joos,
        • P D Paré,
        • and A Sandford
      Thorax 2002;57:6 561-562 doi:10.1136/thorax.57.6.561-a

  4. Jordan, A S

    • Effect of CPAP on intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD Thorax 2002;57:6 533-539 doi:10.1136/thorax.57.6.533

K

  1. Kanazawa, H

    • Decreased peroxynitrite inhibitory activity in induced sputum in patients with bronchial asthma Thorax 2002;57:6 509-512 doi:10.1136/thorax.57.6.509

  2. Karjalainen, J

    • IL-1 haplotypes and lung function decline
      1. Commentator:
        • L Joos,
        • P D Paré,
        • and A Sandford
      Thorax 2002;57:6 561-562 doi:10.1136/thorax.57.6.561-a

  3. Kelly, M

    • Pathophysiology of COPD
      1. Commentator:
        • M A Dentener,
        • E C Creutzberg,
        • and E F M Wouters
      Thorax 2002;57:6 563-564 doi:10.1136/thorax.57.6.563-a

  4. Köhnlein, T

    • Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature Thorax 2002;57:6 547-554 doi:10.1136/thorax.57.6.547

  5. Kübler, W

    • Peripheral airway obstruction in primary pulmonary hypertension Thorax 2002;57:6 473-476 doi:10.1136/thorax.57.6.473

L

  1. Lacasse, Y

    • Independent validation of the Sleep Apnoea Quality of Life Index Thorax 2002;57:6 483-488 doi:10.1136/thorax.57.6.483

  2. Lacey, S

    • Molecular analysis of drug resistant TB Thorax 2002;57:6 562-563 doi:10.1136/thorax.57.6.562

  3. Ledson, M J

    • Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives Thorax 2002;57:6 559-560 doi:10.1136/thorax.57.6.559

  4. Leuppi, J D

    • Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms Thorax 2002;57:6 518-523 doi:10.1136/thorax.57.6.518

M

  1. Magee, J G

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  2. Marks, G B

    • Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms Thorax 2002;57:6 518-523 doi:10.1136/thorax.57.6.518

  3. Matsui, T

    • Relationship between asthma severity and progression of Alzheimer's disease Thorax 2002;57:6 561 doi:10.1136/thorax.57.6.561

  4. McCallum, S J

    • Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives Thorax 2002;57:6 559-560 doi:10.1136/thorax.57.6.559

  5. McEvoy, R D

    • Effect of CPAP on intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD Thorax 2002;57:6 533-539 doi:10.1136/thorax.57.6.533

  6. McHugh, T D

    • Molecular analysis of drug resistant TB Thorax 2002;57:6 562-563 doi:10.1136/thorax.57.6.562

  7. Melzer, M

    • Molecular analysis of drug resistant TB Thorax 2002;57:6 562-563 doi:10.1136/thorax.57.6.562

  8. Meyer, F J

    • Peripheral airway obstruction in primary pulmonary hypertension Thorax 2002;57:6 473-476 doi:10.1136/thorax.57.6.473

  9. Middleton, A M

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  10. Middleton, P G

    • Sleep disordered breathing and pregnancy Thorax 2002;57:6 555-558 doi:10.1136/thorax.57.6.555

  11. Mitchell, D B

    • Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor Thorax 2002;57:6 524-527 doi:10.1136/thorax.57.6.524

O

  1. O'Donoghue, F J

    • Effect of CPAP on intrinsic PEEP, inspiratory effort, and lung volume in severe stable COPD Thorax 2002;57:6 533-539 doi:10.1136/thorax.57.6.533

  2. Ohrui, T

    • Relationship between asthma severity and progression of Alzheimer's disease Thorax 2002;57:6 561 doi:10.1136/thorax.57.6.561

  3. Olschewski, H

    • Peripheral airway obstruction in primary pulmonary hypertension Thorax 2002;57:6 473-476 doi:10.1136/thorax.57.6.473

P

  1. Paré, P D

    • IL-1 haplotypes and lung function decline
      1. Commentator:
        • L Joos,
        • P D Paré,
        • and A Sandford
      Thorax 2002;57:6 561-562 doi:10.1136/thorax.57.6.561-a

  2. Partridge, M

    • Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study Thorax 2002;57:6 503-508 doi:10.1136/thorax.57.6.503

  3. Peebles, R S, Jr

    • Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor Thorax 2002;57:6 524-527 doi:10.1136/thorax.57.6.524

  4. Pini, L

    • Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest Thorax 2002;57:6 528-532 doi:10.1136/thorax.57.6.528

R

  1. Ratcliffe, J

    • Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study Thorax 2002;57:6 503-508 doi:10.1136/thorax.57.6.503

  2. Rayner, A

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  3. Roberts, K T

    • Effects of daily variation in outdoor particulates and ambient acid species in normal and asthmatic children Thorax 2002;57:6 489-502 doi:10.1136/thorax.57.6.489

S

  1. Salome, C M

    • Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms Thorax 2002;57:6 518-523 doi:10.1136/thorax.57.6.518

  2. Sandford, A

    • IL-1 haplotypes and lung function decline
      1. Commentator:
        • L Joos,
        • P D Paré,
        • and A Sandford
      Thorax 2002;57:6 561-562 doi:10.1136/thorax.57.6.561-a

  3. Sasaki, H

    • Relationship between asthma severity and progression of Alzheimer's disease Thorax 2002;57:6 561 doi:10.1136/thorax.57.6.561

  4. Sériés, F

    • Independent validation of the Sleep Apnoea Quality of Life Index Thorax 2002;57:6 483-488 doi:10.1136/thorax.57.6.483

  5. Sheller, J R

    • Suppression of airway hyperresponsiveness induced by ovalbumin sensitisation and RSV infection with Y-27632, a Rho kinase inhibitor Thorax 2002;57:6 524-527 doi:10.1136/thorax.57.6.524

  6. Shiraishi, S

    • Decreased peroxynitrite inhibitory activity in induced sputum in patients with bronchial asthma Thorax 2002;57:6 509-512 doi:10.1136/thorax.57.6.509

  7. Smith, E G

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  8. Storring, R A

    • Molecular analysis of drug resistant TB Thorax 2002;57:6 562-563 doi:10.1136/thorax.57.6.562

  9. Sullivan, C E

    • Sleep disordered breathing and pregnancy Thorax 2002;57:6 555-558 doi:10.1136/thorax.57.6.555

T

  1. Tang, M

    • Influence of family income on hospital visits for asthma among Canadian school children Thorax 2002;57:6 513-517 doi:10.1136/thorax.57.6.513

  2. Tan, L B

    • Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature Thorax 2002;57:6 547-554 doi:10.1136/thorax.57.6.547

  3. Tantucci, C

    • Volume effect and exertional dyspnoea after bronchodilator in patients with COPD with and without expiratory flow limitation at rest Thorax 2002;57:6 528-532 doi:10.1136/thorax.57.6.528

  4. Thompson, C S

    • Lung bullae and marijuana Thorax 2002;57:6 563 doi:10.1136/thorax.57.6.563

V

  1. Van Haselen, R

    • Assessing patients' preferences for characteristics associated with homeopathic and conventional treatment of asthma: a conjoint analysis study Thorax 2002;57:6 503-508 doi:10.1136/thorax.57.6.503

W

  1. Walshaw, M J

    • Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives Thorax 2002;57:6 559-560 doi:10.1136/thorax.57.6.559

  2. Walters, S

    • Effects of daily variation in outdoor particulates and ambient acid species in normal and asthmatic children Thorax 2002;57:6 489-502 doi:10.1136/thorax.57.6.489

  3. Ward, D J

    • Effects of daily variation in outdoor particulates and ambient acid species in normal and asthmatic children Thorax 2002;57:6 489-502 doi:10.1136/thorax.57.6.489

  4. Watson, J M

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  5. Watt, B

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  6. Welte, T

    • Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature Thorax 2002;57:6 547-554 doi:10.1136/thorax.57.6.547

  7. White, R J

    • Lung bullae and marijuana Thorax 2002;57:6 563 doi:10.1136/thorax.57.6.563

  8. Wilkens, H

    • Peripheral airway obstruction in primary pulmonary hypertension Thorax 2002;57:6 473-476 doi:10.1136/thorax.57.6.473

  9. Williams, R

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  10. Winkler, J

    • Peripheral airway obstruction in primary pulmonary hypertension Thorax 2002;57:6 473-476 doi:10.1136/thorax.57.6.473

  11. Wouters, E F M

    • Pathophysiology of COPD
      1. Commentator:
        • M A Dentener,
        • E C Creutzberg,
        • and E F M Wouters
      Thorax 2002;57:6 563-564 doi:10.1136/thorax.57.6.563-a

Y

  1. Yamaya, M

    • Relationship between asthma severity and progression of Alzheimer's disease Thorax 2002;57:6 561 doi:10.1136/thorax.57.6.561

  2. Yates, M

    • Antibiotic resistant tuberculosis in the United Kingdom: 1993–1999 Thorax 2002;57:6 477-482 doi:10.1136/thorax.57.6.477

  3. Yoshikawa, J

    • Decreased peroxynitrite inhibitory activity in induced sputum in patients with bronchial asthma Thorax 2002;57:6 509-512 doi:10.1136/thorax.57.6.509

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.